These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16796710

  • 1. A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer.
    Simonneau G, Laporte S, Mismetti P, Derlon A, Samii K, Samama CM, Bergman JF, FX140 Study Investigators.
    J Thromb Haemost; 2006 Aug; 4(8):1693-700. PubMed ID: 16796710
    [Abstract] [Full Text] [Related]

  • 2. Enoxaparin vs. nadroparin for venous thromboembolism prevention: too close to tell?
    Tosetto A.
    J Thromb Haemost; 2006 Aug; 4(8):1691-2. PubMed ID: 16879210
    [No Abstract] [Full Text] [Related]

  • 3. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
    Turpie AG, Bauer KA, Eriksson BI, Lassen MR.
    Arch Intern Med; 2002 Sep 09; 162(16):1833-40. PubMed ID: 12196081
    [Abstract] [Full Text] [Related]

  • 4. Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.
    Colwell CW, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.
    J Thromb Haemost; 2003 Oct 09; 1(10):2119-30. PubMed ID: 14521593
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial.
    Navarro-Quilis A, Castellet E, Rocha E, Paz-Jiménez J, Planès A, Bemiparin Study Group in Knee Arthroplasty.
    J Thromb Haemost; 2003 Mar 09; 1(3):425-32. PubMed ID: 12871445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH, Spiro TE, Trowbridge AA, Gardiner GA, Whitsett TL, O'Connell MB, Ohar JA, Young TR, Enoxaparin Clinical Trial Group.
    J Bone Joint Surg Am; 2001 Jun 09; 83(6):900-6. PubMed ID: 11407799
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
    Righini M, Galanaud JP, Guenneguez H, Brisot D, Diard A, Faisse P, Barrellier MT, Hamel-Desnos C, Jurus C, Pichot O, Martin M, Mazzolai L, Choquenet C, Accassat S, Robert-Ebadi H, Carrier M, Le Gal G, Mermilllod B, Laroche JP, Bounameaux H, Perrier A, Kahn SR, Quere I.
    Lancet Haematol; 2016 Dec 09; 3(12):e556-e562. PubMed ID: 27836513
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
    Eriksson BI, Bauer KA, Lassen MR, Turpie AG, Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study.
    N Engl J Med; 2001 Nov 01; 345(18):1298-304. PubMed ID: 11794148
    [Abstract] [Full Text] [Related]

  • 15. Selecting an anticoagulant for recurrent venous thromboembolism in cancer.
    Goodin S.
    Am J Health Syst Pharm; 2005 Nov 15; 62(22 Suppl 5):S10-3. PubMed ID: 16286363
    [Abstract] [Full Text] [Related]

  • 16. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer KA, Eriksson BI, Lassen MR, Turpie AG, Steering Committee of the Pentasaccharide in Major Knee Surgery Study.
    N Engl J Med; 2001 Nov 01; 345(18):1305-10. PubMed ID: 11794149
    [Abstract] [Full Text] [Related]

  • 17. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
    Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Simioni P, Ntita K, Salmistraro G, Frangos C, Rossi F, Cordova R, Franz F, Zucchetta P, Kontothanassis D, Andreozzi GM, KANT (Knee Arthroscopy Nadroparin Thromboprophylaxis) Study Group.
    Ann Intern Med; 2008 Jul 15; 149(2):73-82. PubMed ID: 18626046
    [Abstract] [Full Text] [Related]

  • 18. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG, Bauer KA, Davidson BL, Fisher WD, Gent M, Huo MH, Sinha U, Gretler DD, EXPERT Study Group.
    Thromb Haemost; 2009 Jan 15; 101(1):68-76. PubMed ID: 19132191
    [Abstract] [Full Text] [Related]

  • 19. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.
    Superficial Thrombophlebitis Treated By Enoxaparin Study Group.
    Arch Intern Med; 2003 Jul 28; 163(14):1657-63. PubMed ID: 12885680
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.
    Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Compan D, Saliba E, Weisslinger N, Huet Y.
    Drugs; 1996 Jul 28; 52 Suppl 7():47-54. PubMed ID: 9042560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.